-
1
-
-
79959573040
-
Endpoints and clinical trial design for nonalcoholic steatohepatitis
-
PID: 21520200
-
Sanyal AJ, Brunt EM, Kleiner DE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54:344–53.
-
(2011)
Hepatology
, vol.54
, pp. 344-353
-
-
Sanyal, A.J.1
Brunt, E.M.2
Kleiner, D.E.3
-
2
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: a population-based cohort study
-
PID: 16012941
-
Adams LA, Lymp JF, StSauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–21.
-
(2005)
Gastroenterology
, vol.129
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
StSauver, J.3
-
3
-
-
33644700376
-
Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients
-
COI: 1:CAS:528:DC%2BD2MXht12gsL%2FN, PID: 16306373
-
Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes. 2005;54:3541–6.
-
(2005)
Diabetes
, vol.54
, pp. 3541-3546
-
-
Targher, G.1
Bertolini, L.2
Poli, F.3
-
4
-
-
33750606061
-
Long-term follow-up of patients with NAFLD and elevated liver enzymes
-
COI: 1:CAS:528:DC%2BD28XhtFyqsrzN, PID: 17006923
-
Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–73.
-
(2006)
Hepatology
, vol.44
, pp. 865-873
-
-
Ekstedt, M.1
Franzén, L.E.2
Mathiesen, U.L.3
-
5
-
-
67649306197
-
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
-
COI: 1:CAS:528:DC%2BD1MXnvVams7g%3D, PID: 19501928
-
Argo CK, Argo CK, Northup PG, et al. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol. 2009;51:371–9.
-
(2009)
J Hepatol
, vol.51
, pp. 371-379
-
-
Argo, C.K.1
Argo, C.K.2
Northup, P.G.3
-
6
-
-
75449088414
-
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
-
PID: 20014114
-
Söderberg C, Stål P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology. 2010;51:595–602.
-
(2010)
Hepatology
, vol.51
, pp. 595-602
-
-
Söderberg, C.1
Stål, P.2
Askling, J.3
-
7
-
-
80555136061
-
Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
-
PID: 21039302
-
Musso G, Gambino R, Cassader M, et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43:617–49.
-
(2011)
Ann Med
, vol.43
, pp. 617-649
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
-
8
-
-
79960029926
-
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
-
COI: 1:STN:280:DC%2BC3MnlsVamsg%3D%3D, PID: 21623852
-
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274–85.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 274-285
-
-
Vernon, G.1
Baranova, A.2
Younossi, Z.M.3
-
9
-
-
78650486196
-
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study
-
PID: 20858492
-
Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–31.
-
(2011)
Gastroenterology
, vol.140
, pp. 124-131
-
-
Williams, C.D.1
Stengel, J.2
Asike, M.I.3
-
10
-
-
80053581540
-
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
-
PID: 21726509
-
Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141:1249–53.
-
(2011)
Gastroenterology
, vol.141
, pp. 1249-1253
-
-
Charlton, M.R.1
Burns, J.M.2
Pedersen, R.A.3
-
11
-
-
7044229778
-
Primary liver cancer: worldwide incidence and trends
-
PID: 15508102
-
Bosch FX, Ribes J, Díaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5–16.
-
(2004)
Gastroenterology
, vol.127
, pp. S5-S16
-
-
Bosch, F.X.1
Ribes, J.2
Díaz, M.3
-
13
-
-
84899447215
-
Obesity-associated mechanisms of hepatocarcinogenesis
-
COI: 1:CAS:528:DC%2BC2cXkt1Wjs7c%3D, PID: 24629562
-
Karagozian R, Derdák Z, Baffy G. Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism. 2014;63:607–17.
-
(2014)
Metabolism.
, vol.63
, pp. 607-617
-
-
Karagozian, R.1
Derdák, Z.2
Baffy, G.3
-
14
-
-
84919464333
-
Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population
-
COI: 1:CAS:528:DC%2BC3sXhs12qtLvE, PID: 24170184
-
Imamura Y, Uto H, Hiramine Y, et al. Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population. J Gastroenterol. 2014;49:1406–13.
-
(2014)
J Gastroenterol
, vol.49
, pp. 1406-1413
-
-
Imamura, Y.1
Uto, H.2
Hiramine, Y.3
-
15
-
-
79960215555
-
Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period
-
COI: 1:CAS:528:DC%2BC3MXns12mt7c%3D, PID: 21302121
-
Hamabe A, Uto H, Imamura Y, et al. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol. 2011;46:769–78.
-
(2011)
J Gastroenterol
, vol.46
, pp. 769-778
-
-
Hamabe, A.1
Uto, H.2
Imamura, Y.3
-
16
-
-
84865126374
-
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study
-
COI: 1:CAS:528:DC%2BC38Xnsl2msbY%3D, PID: 22328022
-
Eguchi Y, Hyogo H, Ono M, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol. 2012;47:586–95.
-
(2012)
J Gastroenterol
, vol.47
, pp. 586-595
-
-
Eguchi, Y.1
Hyogo, H.2
Ono, M.3
-
17
-
-
84859345557
-
Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome
-
COI: 1:CAS:528:DC%2BC38Xls1GisLo%3D, PID: 22509083
-
Hamaguchi M, Takeda N, Kojima T, et al. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol. 2012;18:1508–16.
-
(2012)
World J Gastroenterol
, vol.18
, pp. 1508-1516
-
-
Hamaguchi, M.1
Takeda, N.2
Kojima, T.3
-
18
-
-
78650775102
-
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan
-
COI: 1:CAS:528:DC%2BC3MXhslOkt7w%3D, PID: 21199527
-
Okanoue T, Umemura A, Yasui K, et al. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. J Gastroenterol Hepatol. 2011;26:153–62.
-
(2011)
J Gastroenterol Hepatol
, vol.26
, pp. 153-162
-
-
Okanoue, T.1
Umemura, A.2
Yasui, K.3
-
19
-
-
84923019742
-
-
J Gastroenterol: Epub ahead of print)
-
Tateishi R, Okanoue T, Fujiwara N, et al. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. J Gastroenterol. 2014 (Epub ahead of print).
-
(2014)
Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study
-
-
Tateishi, R.1
Okanoue, T.2
Fujiwara, N.3
-
20
-
-
84863601615
-
Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis
-
COI: 1:CAS:528:DC%2BC38XhtFGgs7vO, PID: 22523334
-
Zhang ZJ, Zheng ZJ, Shi R, et al. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:2347–53.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 2347-2353
-
-
Zhang, Z.J.1
Zheng, Z.J.2
Shi, R.3
-
21
-
-
63049133092
-
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
-
PID: 19224838
-
Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485–91.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1485-1491
-
-
Altekruse, S.F.1
McGlynn, K.A.2
Reichman, M.E.3
-
22
-
-
84861197159
-
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace
-
PID: 22326465
-
Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol. 2012;56:1384–91.
-
(2012)
J Hepatol
, vol.56
, pp. 1384-1391
-
-
Baffy, G.1
Brunt, E.M.2
Caldwell, S.H.3
-
23
-
-
84055193440
-
Hepatocellular carcinoma in non-alcoholic steatohepatitis: growing evidence of an epidemic?
-
PID: 21917086
-
Hashimoto E, Tokushige K. Hepatocellular carcinoma in non-alcoholic steatohepatitis: growing evidence of an epidemic? Hepatol Res. 2012;42:1–14.
-
(2012)
Hepatol Res
, vol.42
, pp. 1-14
-
-
Hashimoto, E.1
Tokushige, K.2
-
24
-
-
84863340542
-
Recent trend of clinical features in patients with hepatocellular carcinoma
-
COI: 1:CAS:528:DC%2BC38Xot1ehsr4%3D, PID: 22151896
-
Nagaoki Y, Hyogo H, Aikata H, et al. Recent trend of clinical features in patients with hepatocellular carcinoma. Hepatol Res. 2012;42:368–75.
-
(2012)
Hepatol Res
, vol.42
, pp. 368-375
-
-
Nagaoki, Y.1
Hyogo, H.2
Aikata, H.3
-
25
-
-
84856736177
-
Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma
-
COI: 1:CAS:528:DC%2BC38XitFanu78%3D, PID: 22008893
-
Kawamura Y, Arase Y, Ikeda K, et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol. 2012;107:253–61.
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 253-261
-
-
Kawamura, Y.1
Arase, Y.2
Ikeda, K.3
-
26
-
-
84863126563
-
Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients
-
PID: 22175908
-
Arase Y, Kobayashi M, Suzuki F, et al. Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients. Hepatol Res. 2012;42:264–72.
-
(2012)
Hepatol Res
, vol.42
, pp. 264-272
-
-
Arase, Y.1
Kobayashi, M.2
Suzuki, F.3
-
27
-
-
58849132440
-
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
-
COI: 1:CAS:528:DC%2BD1MXjslKksr0%3D, PID: 19032450
-
Yatsuji S, Hashimoto E, Tobari M, et al. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol. 2009;24:248–54.
-
(2009)
J Gastroenterol Hepatol
, vol.24
, pp. 248-254
-
-
Yatsuji, S.1
Hashimoto, E.2
Tobari, M.3
-
28
-
-
50549084740
-
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
-
PID: 18682312
-
Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol. 2008;49:608–12.
-
(2008)
J Hepatol
, vol.49
, pp. 608-612
-
-
Ong, J.P.1
Pitts, A.2
Younossi, Z.M.3
-
29
-
-
58849134985
-
Long-term follow-up of patients with nonalcoholic fatty liver
-
PID: 19049831
-
Rafiq N, Bai C, Fang Y, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7:234–8.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 234-238
-
-
Rafiq, N.1
Bai, C.2
Fang, Y.3
-
30
-
-
77951456114
-
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection
-
PID: 20432259
-
Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51:1820–32.
-
(2010)
Hepatology
, vol.51
, pp. 1820-1832
-
-
Starley, B.Q.1
Calcagno, C.J.2
Harrison, S.A.3
-
31
-
-
77952730428
-
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
-
PID: 20209604
-
Ascha MS, Hanouneh IA, Lopez R, et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51:1972–8.
-
(2010)
Hepatology
, vol.51
, pp. 1972-1978
-
-
Ascha, M.S.1
Hanouneh, I.A.2
Lopez, R.3
-
32
-
-
33645963121
-
Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
-
PID: 16502396
-
Sanyal AJ, Banas C, Sargeant C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology. 2006;43:682–9.
-
(2006)
Hepatology
, vol.43
, pp. 682-689
-
-
Sanyal, A.J.1
Banas, C.2
Sargeant, C.3
-
33
-
-
79960549297
-
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study
-
PID: 21688282
-
Bhala N, Angulo P, van der Poorten D, et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology. 2011;54:1208–16.
-
(2011)
Hepatology
, vol.54
, pp. 1208-1216
-
-
Bhala, N.1
Angulo, P.2
van der Poorten, D.3
-
34
-
-
84869436442
-
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review
-
PID: 23041539
-
White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol. 2012;10:1342–59.
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, pp. 1342-1359
-
-
White, D.L.1
Kanwal, F.2
El-Serag, H.B.3
-
35
-
-
79957521377
-
Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality
-
PID: 21360720
-
Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology. 2011;53:1874–82.
-
(2011)
Hepatology
, vol.53
, pp. 1874-1882
-
-
Younossi, Z.M.1
Stepanova, M.2
Rafiq, N.3
-
36
-
-
58849090967
-
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
-
PID: 19148800
-
Hashimoto E, Yatsuji S, Tobari M, et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol. 2009;44:89–95.
-
(2009)
J Gastroenterol
, vol.44
, pp. 89-95
-
-
Hashimoto, E.1
Yatsuji, S.2
Tobari, M.3
-
37
-
-
77955625142
-
Population-based risk factors and resource utilization for HCC: US perspective
-
COI: 1:STN:280:DC%2BC3cjkslyhug%3D%3D, PID: 20666689
-
Sanyal A, Poklepovic A, Moyneur E, et al. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin. 2010;26:2183–91.
-
(2010)
Curr Med Res Opin
, vol.26
, pp. 2183-2191
-
-
Sanyal, A.1
Poklepovic, A.2
Moyneur, E.3
-
38
-
-
24044467100
-
Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults
-
COI: 1:CAS:528:DC%2BD2MXhtVOlt7%2FO, PID: 16108839
-
Jimba S, Nakagami T, Takahashi M, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med. 2005;22:1141–5.
-
(2005)
Diabet Med
, vol.22
, pp. 1141-1145
-
-
Jimba, S.1
Nakagami, T.2
Takahashi, M.3
-
39
-
-
35649017612
-
Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis
-
COI: 1:CAS:528:DC%2BD2sXhsVGju7%2FF, PID: 17610504
-
Yatsuji S, Hashimoto E, Tobari M, et al. Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis. Hepatol Res. 2007;37:1034–43.
-
(2007)
Hepatol Res.
, vol.37
, pp. 1034-1043
-
-
Yatsuji, S.1
Hashimoto, E.2
Tobari, M.3
-
40
-
-
78651352067
-
Prevalence, gender, ethnic variations, and prognosis of NASH
-
PID: 20844903
-
Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol. 2011;46:63–9.
-
(2011)
J Gastroenterol
, vol.46
, pp. 63-69
-
-
Hashimoto, E.1
Tokushige, K.2
-
41
-
-
79955033727
-
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma
-
PID: 21320639
-
Yasui K, Hashimoto E, Komorizono Y, et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011;9:428–33.
-
(2011)
Clin Gastroenterol Hepatol.
, vol.9
, pp. 428-433
-
-
Yasui, K.1
Hashimoto, E.2
Komorizono, Y.3
-
42
-
-
84855774531
-
Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma
-
PID: 22251466
-
Duan XY, Qiao L, Fan JG. Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2012;11:18–27.
-
(2012)
Hepatobiliary Pancreat Dis Int
, vol.11
, pp. 18-27
-
-
Duan, X.Y.1
Qiao, L.2
Fan, J.G.3
-
43
-
-
84872613896
-
Metabolic syndrome and hepatocellular carcinoma risk
-
COI: 1:STN:280:DC%2BC3s7ltFOksg%3D%3D, PID: 23169288
-
Turati F, Talamini R, Pelucchi C, et al. Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer. 2013;108:222–8.
-
(2013)
Br J Cancer
, vol.108
, pp. 222-228
-
-
Turati, F.1
Talamini, R.2
Pelucchi, C.3
-
44
-
-
0037464510
-
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
-
PID: 12711737
-
Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.
-
(2003)
N Engl J Med
, vol.348
, pp. 1625-1638
-
-
Calle, E.E.1
Rodriguez, C.2
Walker-Thurmond, K.3
-
45
-
-
84860215803
-
Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
-
COI: 1:CAS:528:DC%2BC38XlslyrsLc%3D, PID: 21805476
-
Borena W, Strohmaier S, Lukanova A, et al. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer. 2012;131:193–200.
-
(2012)
Int J Cancer
, vol.131
, pp. 193-200
-
-
Borena, W.1
Strohmaier, S.2
Lukanova, A.3
-
46
-
-
84870251301
-
Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort
-
COI: 1:CAS:528:DC%2BC38XotlCrtrw%3D, PID: 22618881
-
Schlesinger S, Aleksandrova K, Pischon T, et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer. 2013;132:645–57.
-
(2013)
Int J Cancer
, vol.132
, pp. 645-657
-
-
Schlesinger, S.1
Aleksandrova, K.2
Pischon, T.3
-
47
-
-
34948867745
-
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies
-
COI: 1:STN:280:DC%2BD2srovFSjsg%3D%3D, PID: 17700568
-
Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer. 2007;97:1005–8.
-
(2007)
Br J Cancer
, vol.97
, pp. 1005-1008
-
-
Larsson, S.C.1
Wolk, A.2
-
48
-
-
79960747094
-
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database
-
PID: 21538440
-
Welzel TM, Graubard BI, Zeuzem S, et al. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology. 2011;54:463–71.
-
(2011)
Hepatology
, vol.54
, pp. 463-471
-
-
Welzel, T.M.1
Graubard, B.I.2
Zeuzem, S.3
-
49
-
-
77953971188
-
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
-
PID: 20581244
-
Wong VW, Wong GL, Choi PC, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut. 2010;59:969–74.
-
(2010)
Gut
, vol.59
, pp. 969-974
-
-
Wong, V.W.1
Wong, G.L.2
Choi, P.C.3
-
50
-
-
73449116035
-
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
-
COI: 1:CAS:528:DC%2BC3cXhsVCqtbg%3D, PID: 19827166
-
Promrat K, Kleiner DE, Niemeier HM, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010;51:121–9.
-
(2010)
Hepatology
, vol.51
, pp. 121-129
-
-
Promrat, K.1
Kleiner, D.E.2
Niemeier, H.M.3
-
51
-
-
33749031867
-
Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan
-
PID: 17000944
-
Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166:1871–7.
-
(2006)
Arch Intern Med
, vol.166
, pp. 1871-1877
-
-
Inoue, M.1
Iwasaki, M.2
Otani, T.3
-
52
-
-
77956227260
-
Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan
-
PID: 20656522
-
Noto H, Osame K, Sasazuki T, et al. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complicat. 2010;24:345–53.
-
(2010)
J Diabetes Complicat
, vol.24
, pp. 345-353
-
-
Noto, H.1
Osame, K.2
Sasazuki, T.3
-
53
-
-
77954237223
-
Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications
-
PID: 20578004
-
Chen HF, Chen P, Li CY. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology. 2010;52:155–63.
-
(2010)
Hepatology
, vol.52
, pp. 155-163
-
-
Chen, H.F.1
Chen, P.2
Li, C.Y.3
-
54
-
-
84875463056
-
Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study
-
PID: 23370206
-
Koh WP, Wang R, Jin A, et al. Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Br J Cancer. 2013;108:1182–8.
-
(2013)
Br J Cancer
, vol.108
, pp. 1182-1188
-
-
Koh, W.P.1
Wang, R.2
Jin, A.3
-
55
-
-
0842321807
-
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
-
PID: 14762783
-
El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126:460–8.
-
(2004)
Gastroenterology
, vol.126
, pp. 460-468
-
-
El-Serag, H.B.1
Tran, T.2
Everhart, J.E.3
-
56
-
-
79961218135
-
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies
-
COI: 1:CAS:528:DC%2BC38Xhtl2gsbc%3D, PID: 21544812
-
Wang C, Wang X, Gong G, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer. 2012;130:1639–48.
-
(2012)
Int J Cancer
, vol.130
, pp. 1639-1648
-
-
Wang, C.1
Wang, X.2
Gong, G.3
-
57
-
-
67049114700
-
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol
-
COI: 1:CAS:528:DC%2BD1MXjs12ksbc%3D, PID: 19058085
-
Yasutake K, Nakamuta M, Shima Y, et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol. 2009;44:471–7.
-
(2009)
Scand J Gastroenterol
, vol.44
, pp. 471-477
-
-
Yasutake, K.1
Nakamuta, M.2
Shima, Y.3
-
58
-
-
84872492049
-
Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3sXovFWlsg%3D%3D, PID: 23178552
-
Leamy AK, Egnatchik RA, Young JD. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res. 2013;52:165–74.
-
(2013)
Prog Lipid Res
, vol.52
, pp. 165-174
-
-
Leamy, A.K.1
Egnatchik, R.A.2
Young, J.D.3
-
59
-
-
77449157160
-
Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?
-
COI: 1:CAS:528:DC%2BC3cXhvF2is7c%3D, PID: 20143458
-
Enjoji M, Nakamuta M. Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease? World J Gastroenterol. 2010;16:800–3.
-
(2010)
World J Gastroenterol
, vol.16
, pp. 800-803
-
-
Enjoji, M.1
Nakamuta, M.2
-
60
-
-
84866686183
-
Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol
-
COI: 1:CAS:528:DC%2BC38XhslOiu7bL, PID: 22809366
-
Hosoyamada K, Uto H, Imamura Y, et al. Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol. Diabetol Metab Syndr. 2012;4:34.
-
(2012)
Diabetol Metab Syndr
, vol.4
, pp. 34
-
-
Hosoyamada, K.1
Uto, H.2
Imamura, Y.3
-
61
-
-
56749096610
-
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BD1cXhsVWgsrrP, PID: 18820647
-
Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461–5.
-
(2008)
Nat Genet
, vol.40
, pp. 1461-1465
-
-
Romeo, S.1
Kozlitina, J.2
Xing, C.3
-
62
-
-
78650336759
-
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3MXisFamsg%3D%3D, PID: 21176169
-
Hotta K, Yoneda M, Hyogo H, et al. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med Genet. 2010;11:172.
-
(2010)
BMC Med Genet
, vol.11
, pp. 172
-
-
Hotta, K.1
Yoneda, M.2
Hyogo, H.3
-
63
-
-
84862267335
-
Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese
-
COI: 1:CAS:528:DC%2BC38XptVyktbg%3D, PID: 22719876
-
Kawaguchi T, Sumida Y, Umemura A, et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE. 2012;7:e38322.
-
(2012)
PLoS ONE
, vol.7
, pp. e38322
-
-
Kawaguchi, T.1
Sumida, Y.2
Umemura, A.3
-
64
-
-
79957462315
-
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3MXmsFCqtrg%3D, PID: 21381068
-
Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology. 2011;53:1883–94.
-
(2011)
Hepatology
, vol.53
, pp. 1883-1894
-
-
Sookoian, S.1
Pirola, C.J.2
-
65
-
-
84879499129
-
Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan
-
COI: 1:CAS:528:DC%2BC3sXps1ymsL4%3D, PID: 23535911
-
Kitamoto T, Kitamoto A, Yoneda M, et al. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet. 2013;132:783–92.
-
(2013)
Hum Genet
, vol.132
, pp. 783-792
-
-
Kitamoto, T.1
Kitamoto, A.2
Yoneda, M.3
-
66
-
-
84902688337
-
Carriage of the PNPLA3 rs738409 C>G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
-
COI: 1:CAS:528:DC%2BC2cXmtlCqs7c%3D, PID: 24607626
-
Liu YL, Patman GL, Leathart JB, et al. Carriage of the PNPLA3 rs738409 C>G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J Hepatol. 2014;61:75–81.
-
(2014)
J Hepatol
, vol.61
, pp. 75-81
-
-
Liu, Y.L.1
Patman, G.L.2
Leathart, J.B.3
-
67
-
-
79959826790
-
Alcohol drinking patterns and the risk of fatty liver in Japanese men
-
COI: 1:CAS:528:DC%2BC3MXovVyksLc%3D, PID: 20967556
-
Hiramine Y, Imamura Y, Uto H, et al. Alcohol drinking patterns and the risk of fatty liver in Japanese men. J Gastroenterol. 2011;46:519–28.
-
(2011)
J Gastroenterol
, vol.46
, pp. 519-528
-
-
Hiramine, Y.1
Imamura, Y.2
Uto, H.3
-
68
-
-
79952701706
-
Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3MXjs12iu7c%3D, PID: 21126792
-
Zein CO, Unalp A, Colvin R, et al. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol. 2011;54:753–9.
-
(2011)
J Hepatol
, vol.54
, pp. 753-759
-
-
Zein, C.O.1
Unalp, A.2
Colvin, R.3
-
69
-
-
80055021248
-
Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study
-
PID: 21915129
-
Koh WP, Robien K, Wang R, et al. Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer. 2011;105:1430–5.
-
(2011)
Br J Cancer
, vol.105
, pp. 1430-1435
-
-
Koh, W.P.1
Robien, K.2
Wang, R.3
-
70
-
-
0031947715
-
Steatohepatitis: a tale of two “hits”?
-
COI: 1:STN:280:DyaK1c3htFartQ%3D%3D, PID: 9547102
-
Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–5.
-
(1998)
Gastroenterology
, vol.114
, pp. 842-845
-
-
Day, C.P.1
James, O.F.2
-
71
-
-
78049522194
-
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis
-
COI: 1:CAS:528:DC%2BC3cXhsFOnsrjP, PID: 21038418
-
Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52:1836–46.
-
(2010)
Hepatology
, vol.52
, pp. 1836-1846
-
-
Tilg, H.1
Moschen, A.R.2
-
72
-
-
33644888156
-
Liver disease in patients with diabetes mellitus
-
PID: 16340637
-
Harrison SA. Liver disease in patients with diabetes mellitus. J Clin Gastroenterol. 2006;40:68–76.
-
(2006)
J Clin Gastroenterol
, vol.40
, pp. 68-76
-
-
Harrison, S.A.1
-
73
-
-
34249699540
-
Non-alcoholic steatohepatitis and cancer
-
COI: 1:STN:280:DC%2BD2szjt1Gguw%3D%3D, PID: 17544979
-
Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis. 2007;11:191–207.
-
(2007)
Clin Liver Dis
, vol.11
, pp. 191-207
-
-
Bugianesi, E.1
-
74
-
-
55249098186
-
White adipose tissue as endocrine organ and its role in obesity
-
PID: 18996284
-
Vázquez-Vela ME, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res. 2008;39:715–28.
-
(2008)
Arch Med Res
, vol.39
, pp. 715-728
-
-
Vázquez-Vela, M.E.1
Torres, N.2
Tovar, A.R.3
-
75
-
-
56649118735
-
Adipocytokines and liver disease
-
COI: 1:CAS:528:DC%2BD1cXhtlyksrrE, PID: 19012034
-
Kamada Y, Takehara T, Hayashi N. Adipocytokines and liver disease. J Gastroenterol. 2008;43:811–22.
-
(2008)
J Gastroenterol
, vol.43
, pp. 811-822
-
-
Kamada, Y.1
Takehara, T.2
Hayashi, N.3
-
76
-
-
74549167737
-
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression
-
COI: 1:CAS:528:DC%2BC3cXkvVWitLw%3D, PID: 20141834
-
Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197–208.
-
(2010)
Cell
, vol.140
, pp. 197-208
-
-
Park, E.J.1
Lee, J.H.2
Yu, G.Y.3
-
77
-
-
84879888338
-
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
-
COI: 1:CAS:528:DC%2BC3sXhtVWgurvK, PID: 23803760
-
Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97–101.
-
(2013)
Nature
, vol.499
, pp. 97-101
-
-
Yoshimoto, S.1
Loo, T.M.2
Atarashi, K.3
-
78
-
-
0036828347
-
Fructose, weight gain, and the insulin resistance syndrome
-
COI: 1:CAS:528:DC%2BD38XosF2ru7k%3D, PID: 12399260
-
Elliott SS, Keim NL, Stern JS, et al. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002;76:911–22.
-
(2002)
Am J Clin Nutr
, vol.76
, pp. 911-922
-
-
Elliott, S.S.1
Keim, N.L.2
Stern, J.S.3
-
79
-
-
2142815151
-
Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity
-
COI: 1:CAS:528:DC%2BD2cXivFykt74%3D, PID: 15051594
-
Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537–43.
-
(2004)
Am J Clin Nutr
, vol.79
, pp. 537-543
-
-
Bray, G.A.1
Nielsen, S.J.2
Popkin, B.M.3
-
80
-
-
41949110748
-
The role of sugar-sweetened beverage consumption in adolescent obesity: a review of the literature
-
PID: 18220450
-
Harrington S. The role of sugar-sweetened beverage consumption in adolescent obesity: a review of the literature. J Sch Nurs. 2008;24:3–12.
-
(2008)
J Sch Nurs
, vol.24
, pp. 3-12
-
-
Harrington, S.1
-
81
-
-
43049170503
-
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BD1cXlvVSksLk%3D, PID: 18395287
-
Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008;48:993–9.
-
(2008)
J Hepatol
, vol.48
, pp. 993-999
-
-
Ouyang, X.1
Cirillo, P.2
Sautin, Y.3
-
82
-
-
49449083979
-
Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake
-
COI: 1:CAS:528:DC%2BD1cXovFWns7c%3D, PID: 18641190
-
Thuy S, Ladurner R, Volynets V, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr. 2008;138:1452–5.
-
(2008)
J Nutr
, vol.138
, pp. 1452-1455
-
-
Thuy, S.1
Ladurner, R.2
Volynets, V.3
-
83
-
-
84879090877
-
Dietary fructose in nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3sXps1Cit78%3D, PID: 23390127
-
Vos MB, Lavine JE. Dietary fructose in nonalcoholic fatty liver disease. Hepatology. 2013;57:2525–31.
-
(2013)
Hepatology
, vol.57
, pp. 2525-2531
-
-
Vos, M.B.1
Lavine, J.E.2
-
84
-
-
84887023370
-
High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase
-
COI: 1:CAS:528:DC%2BC3sXhslWqsLvE, PID: 23813872
-
Ishimoto T, Lanaspa MA, Rivard CJ, et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology. 2013;58:1632–43.
-
(2013)
Hepatology
, vol.58
, pp. 1632-1643
-
-
Ishimoto, T.1
Lanaspa, M.A.2
Rivard, C.J.3
-
85
-
-
77952692915
-
Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3cXnslyqsbg%3D, PID: 20301112
-
Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51:1961–71.
-
(2010)
Hepatology
, vol.51
, pp. 1961-1971
-
-
Abdelmalek, M.F.1
Suzuki, A.2
Guy, C.3
-
86
-
-
1442281989
-
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver
-
COI: 1:CAS:528:DC%2BD2cXjtlCrurY%3D, PID: 14752836
-
Bugianesi E, Manzini P, D’Antico S, et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology. 2004;39:179–87.
-
(2004)
Hepatology
, vol.39
, pp. 179-187
-
-
Bugianesi, E.1
Manzini, P.2
D’Antico, S.3
-
87
-
-
79954442712
-
A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3MXit1Kgt7c%3D, PID: 20842510
-
Sumida Y, Yoneda M, Hyogo H, et al. A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease. J Gastroenterol. 2011;46:257–68.
-
(2011)
J Gastroenterol
, vol.46
, pp. 257-268
-
-
Sumida, Y.1
Yoneda, M.2
Hyogo, H.3
-
88
-
-
84155188801
-
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3MXhs1Ght77J, PID: 21953442
-
Kowdley KV, Belt P, Wilson LA, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012;55:77–85.
-
(2012)
Hepatology
, vol.55
, pp. 77-85
-
-
Kowdley, K.V.1
Belt, P.2
Wilson, L.A.3
-
89
-
-
58149280387
-
Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis
-
COI: 1:CAS:528:DC%2BD1MXntVGhuw%3D%3D, PID: 19070395
-
Sorrentino P, D’Angelo S, Ferbo U, et al. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. J Hepatol. 2009;50:351–7.
-
(2009)
J Hepatol
, vol.50
, pp. 351-357
-
-
Sorrentino, P.1
D’Angelo, S.2
Ferbo, U.3
-
90
-
-
0037566201
-
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
-
PID: 12774006
-
Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;37:1286–92.
-
(2003)
Hepatology
, vol.37
, pp. 1286-1292
-
-
Mofrad, P.1
Contos, M.J.2
Haque, M.3
-
91
-
-
51349083814
-
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
-
COI: 1:CAS:528:DC%2BD1cXhtFKrsLbK, PID: 18752331
-
Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48:792–8.
-
(2008)
Hepatology
, vol.48
, pp. 792-798
-
-
Fracanzani, A.L.1
Valenti, L.2
Bugianesi, E.3
-
92
-
-
84863772732
-
Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma
-
COI: 1:CAS:528:DC%2BC38XhsVensL%2FJ, PID: 22487102
-
Yasui K, Hashimoto E, Tokushige K, et al. Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma. Hepatol Res. 2012;42:767–73.
-
(2012)
Hepatol Res
, vol.42
, pp. 767-773
-
-
Yasui, K.1
Hashimoto, E.2
Tokushige, K.3
-
93
-
-
84655167654
-
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease
-
PID: 21750883
-
Yoneda M, Fujii H, Sumida Y, et al. Platelet count for predicting fibrosis in nonalcoholic fatty liver disease. J Gastroenterol. 2011;46:1300–6.
-
(2011)
J Gastroenterol
, vol.46
, pp. 1300-1306
-
-
Yoneda, M.1
Fujii, H.2
Sumida, Y.3
-
94
-
-
33745904468
-
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BD28XnsFWjtrs%3D, PID: 16799979
-
Wieckowska A, Zein NN, Yerian LM, et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology. 2006;44:27–33.
-
(2006)
Hepatology
, vol.44
, pp. 27-33
-
-
Wieckowska, A.1
Zein, N.N.2
Yerian, L.M.3
-
95
-
-
3042744737
-
Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
-
COI: 1:CAS:528:DC%2BD2cXmtlSgtLY%3D, PID: 15239085
-
Hui JM, Hodge A, Farrell GC, et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology. 2004;40:46–54.
-
(2004)
Hepatology
, vol.40
, pp. 46-54
-
-
Hui, J.M.1
Hodge, A.2
Farrell, G.C.3
-
96
-
-
34547596738
-
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
-
COI: 1:CAS:528:DC%2BD2sXotFygsLg%3D, PID: 17653654
-
Yoneda M, Mawatari H, Fujita K, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol. 2007;42:573–82.
-
(2007)
J Gastroenterol
, vol.42
, pp. 573-582
-
-
Yoneda, M.1
Mawatari, H.2
Fujita, K.3
-
97
-
-
0037232972
-
Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BD38XptlSqt7k%3D, PID: 12480557
-
Sumida Y, Nakashima T, Yoh T, et al. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol. 2003;38:32–8.
-
(2003)
J Hepatol
, vol.38
, pp. 32-38
-
-
Sumida, Y.1
Nakashima, T.2
Yoh, T.3
-
98
-
-
77954373903
-
Identification of a novel biomarker for oxidative stress induced by hydrogen peroxide in primary human hepatocytes using the 2-nitrobenzenesulfenyl chloride isotope labeling method
-
COI: 1:CAS:528:DC%2BC3cXmtlGns7g%3D, PID: 20236361
-
Takami Y, Uto H, Tamai T, et al. Identification of a novel biomarker for oxidative stress induced by hydrogen peroxide in primary human hepatocytes using the 2-nitrobenzenesulfenyl chloride isotope labeling method. Hepatol Res. 2010;40:438–45.
-
(2010)
Hepatol Res
, vol.40
, pp. 438-445
-
-
Takami, Y.1
Uto, H.2
Tamai, T.3
-
99
-
-
70350046669
-
Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study
-
COI: 1:CAS:528:DC%2BD1MXhtlWlu7jL, PID: 19585618
-
Feldstein AE, Wieckowska A, Lopez AR, et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology. 2009;50:1072–8.
-
(2009)
Hepatology
, vol.50
, pp. 1072-1078
-
-
Feldstein, A.E.1
Wieckowska, A.2
Lopez, A.R.3
-
100
-
-
84872716915
-
A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis
-
PID: 23323209
-
Kuno A, Ikehara Y, Tanaka Y, et al. A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013;3:1065.
-
(2013)
Sci Rep
, vol.3
, pp. 1065
-
-
Kuno, A.1
Ikehara, Y.2
Tanaka, Y.3
-
101
-
-
84885947103
-
Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis
-
COI: 1:CAS:528:DC%2BC3sXhsVCnt7zP
-
Kamada Y, Fujii H, Fujii H, et al. Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis. Proteomics Clin Appl. 2013;7:648–56.
-
(2013)
Proteomics Clin Appl
, vol.7
, pp. 648-656
-
-
Kamada, Y.1
Fujii, H.2
Fujii, H.3
-
102
-
-
34247384560
-
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD
-
COI: 1:CAS:528:DC%2BD2sXltlWis7k%3D, PID: 17393509
-
Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846–54.
-
(2007)
Hepatology
, vol.45
, pp. 846-854
-
-
Angulo, P.1
Hui, J.M.2
Marchesini, G.3
-
103
-
-
70349546276
-
Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BD1MXhsFaqtbnK, PID: 19523535
-
Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104–12.
-
(2009)
Clin Gastroenterol Hepatol
, vol.7
, pp. 1104-1112
-
-
Shah, A.G.1
Lydecker, A.2
Murray, K.3
-
104
-
-
84855390033
-
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
-
COI: 1:CAS:528:DC%2BC38XivVWit7s%3D, PID: 22221544
-
Sumida Y, Yoneda M, Hyogo H, et al. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol. 2012;12:2.
-
(2012)
BMC Gastroenterol
, vol.12
, pp. 2
-
-
Sumida, Y.1
Yoneda, M.2
Hyogo, H.3
-
105
-
-
84876130551
-
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
-
COI: 1:CAS:528:DC%2BC3sXlslygu7o%3D, PID: 23175136
-
Kim D, Kim WR, Kim HJ, et al. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013;57:1357–65.
-
(2013)
Hepatology
, vol.57
, pp. 1357-1365
-
-
Kim, D.1
Kim, W.R.2
Kim, H.J.3
-
106
-
-
84885430551
-
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels
-
COI: 1:CAS:528:DC%2BC3sXhsVOktbjN, PID: 23184095
-
Yoneda M, Imajo K, Eguchi Y, et al. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels. J Gastroenterol. 2013;48:1051–60.
-
(2013)
J Gastroenterol
, vol.48
, pp. 1051-1060
-
-
Yoneda, M.1
Imajo, K.2
Eguchi, Y.3
-
107
-
-
41849148981
-
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)
-
COI: 1:CAS:528:DC%2BD1cXns1yhsLc%3D, PID: 18083083
-
Yoneda M, Yoneda M, Mawatari H, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis. 2008;40:371–8.
-
(2008)
Dig Liver Dis
, vol.40
, pp. 371-378
-
-
Yoneda, M.1
Yoneda, M.2
Mawatari, H.3
-
108
-
-
52749093094
-
Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases
-
PID: 18807134
-
Obara N, Ueno Y, Fukushima K, et al. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol. 2008;43:720–8.
-
(2008)
J Gastroenterol
, vol.43
, pp. 720-728
-
-
Obara, N.1
Ueno, Y.2
Fukushima, K.3
-
109
-
-
34447314723
-
Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis
-
PID: 17559420
-
Iijima H, Moriyasu F, Tsuchiya K, et al. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res. 2007;37:722–30.
-
(2007)
Hepatol Res
, vol.37
, pp. 722-730
-
-
Iijima, H.1
Moriyasu, F.2
Tsuchiya, K.3
-
110
-
-
79956292596
-
Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography
-
PID: 21460032
-
Chen J, Talwalkar JA, Yin M, et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology. 2011;259:749–56.
-
(2011)
Radiology
, vol.259
, pp. 749-756
-
-
Chen, J.1
Talwalkar, J.A.2
Yin, M.3
-
111
-
-
84925359459
-
-
Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population, Clin Gastroenterol Hepatol:
-
Mittal S, Sada YH, El-Serag HB, et al. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin Gastroenterol Hepatol. 2014. doi:10.1016/j.cgh.2014.08.013.
-
(2014)
Et al
-
-
Mittal, S.1
Sada, Y.H.2
El-Serag, H.B.3
|